What we know about effective public engagement on CRISPR and beyond.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 34050014.
- Also identified by DOI 10.1073/pnas.2004835117 and PMC identifier 8179128.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Advances in gene editing technologies for human, plant, and animal applications have led to calls from bench and social scientists, as well as a wide variety of societal stakeholders, for broad public engagement in the decision-making about these new technologies. Unfortunately, there is limited understanding among the groups calling for public engagement on CRISPR and other emerging technologies about 1) the goals of this engagement, 2) the modes of engagement and what we know from systematic social scientific evaluations about their effectiveness, and 3) how to connect the products of these engagement exercises to societal decision or policy making. Addressing all three areas, we systematize common goals, principles, and modalities of public engagement. We evaluate empirically the likely successes of various modalities. Finally, we outline three pathways forward that deserve close attention from the scientific community as we navigate the world of Life 2.0.
Medical subject headings
- Biomedical Research
- Clustered Regularly Interspaced Short Palindromic Repeats
- Gene Editing
- Policy Making